Frontage Laboratories Appoints Carlos Orantes As Chief Operating Officer
2/18/2014 9:21:57 AM
Exton, P.A., (February 18, 2014) – Frontage Laboratories today announced that Carlos Orantes has been
appointed Chief Operating Officer. A twenty-year veteran of contract research and life science industries,
he will lead Frontage’s US operations, which comprise a 60,000 square foot laboratory for bioanalysis and
DMPK functions, an 88-bed clinical research unit and a portfolio of CMC services, including product
development, analytical testing and CTM manufacturing.
“Mr. Orantes brings an impressive record of designing and leading successful growth strategies for companies
that are large and small, both private and publicly-held entities,” said Dr. Song Li, Chairman and CEO. “Our
goal is to expand our service offerings to meet shifting industry needs, and make it easier for customers to do
business with us by bringing technical guidance, excellent customer service along with new services to solve
the needs of our customers. I’m confident that Frontage and our customers will significantly benefit from his
business experience driving strategic initiatives as the company enters its next phase of growth.”
“Frontage has a strong commitment to exceptional science, and I am excited to have the opportunity to lead
efforts as we continue to build offerings and customer support that are both integrated and world-class,”
said Mr. Orantes.
Mr. Orantes previously served as President and CEO of AVANZA Laboratories LLC. There, he developed the
company’s business strategy, and led activities related to the company’s asset purchase in 2012 by the
Prior to AVANZA, Mr. Orantes was General Manager and Vice President for Bridge Laboratories, a toxicology
and immunology testing laboratory where he held management responsibility for US operations. Earlier
career positions included 10 years of operational, quality assurance, process improvement and management
roles of increasing responsibility at Covance.
Mr. Orantes earned a master’s of business administration degree from Old Dominion University, and a
bachelor of science degree in biology from George Washington University. He is Six Sigma Black Belt certified
from the Six Sigma Academy.
Frontage helps biopharmaceutical organizations advance their research and development efforts with full
service offerings– including bioanalysis, preclinical and clinical studies, analytical testing and product
development support– spanning discovery stages through late-stage clinical trials. The company also provides
turnkey product development, bioequivalence and analytical services to generic and consumer health
pharmaceutical companies to support Abbreviated NDA and 505.b.2 application submissions.
With a 12-year history of bioanalytical, clinical research and CMC operations, eight state-of-the art research
facilities and more than 320 professionals in the US and China, Frontage has enabled biopharmaceutical and
generic companies of all sizes to advance hundreds of molecules through clinical development and
commercial launch in global markets. For more information, visit www.frontagelab.com.
Help employers find you! Check out all the jobs and post your resume.
comments powered by